FUSION PHARMACEUTICALS INC (FUSN)
CA36118A1003 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 27.79M | 61.46M | 43.90M | 52.90M | 90.50M | |||
| Marketable Securities | 182.74M | 172.15M | 127.00M | 147.90M | 131.90M | |||
| Receivables | 6.21M | 5.47M | 1.70M | 2.60M | 800.00K | |||
| Other Current Assets | 4.18M | 4.31M | 6.40M | 8.40M | 5.00M | |||
| Total Current Assets | 220.92M | 243.40M | 179.00M | 211.80M | 228.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 24.45M | 23.90M | 10.30M | 9.50M | 2.00M | |||
| Investments And Advances | 72.58M | 13.73M | 15.80M | 20.00M | 77.10M | |||
| Other Non-Current Assets | 5.87M | 4.81M | 14.00M | 11.10M | 3.50M | |||
| Total Non-Current Assets | 102.90M | 42.44M | 40.10M | 40.50M | 82.50M | |||
| TOTAL ASSETS | 323.81M | 285.84M | 219.10M | 252.30M | 310.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 17.87M | 13.94M | 11.40M | 8.80M | 4.70M | |||
| Accounts Payable | 2.50M | 1.86M | 2.70M | 2.20M | 3.40M | |||
| Other Current Liabilities | 382.00K | 417.00K | 1.00M | 1.50M | 3.80M | |||
| Total Current Liabilities | 20.76M | 16.22M | 15.10M | 12.50M | 11.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 49.69M | 34.77M | 34.20M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 11.54M | 12.36M | 7.50M | 8.30M | 4.30M | |||
| Total Non-Current Liabilities | 61.23M | 47.14M | 41.70M | 8.30M | 4.30M | |||
| TOTAL LIABILITIES | 81.98M | 63.36M | 56.80M | 20.80M | 16.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -410.43M | -376.76M | -281.90M | -194.30M | -113.20M | |||
| Additional Paid In Capital | 652.84M | 599.00M | 444.60M | 425.80M | 407.70M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 0.00 | 0.00 | 0.00 | N/A | 0.00 | |||
| Other Shareholders' Equity | -582.00K | 237.00K | -500.00K | -100.00K | 0.00 | |||
| Shares Outstanding | 84.87M | 79.70M | 44.80M | 43.10M | 41.70M | |||
| Tangible Book Value per Share | 2.85 | 2.79 | 3.62 | 5.37 | 7.06 | |||
| Total Shareholders' Equity | 241.83M | 222.48M | 162.20M | 231.50M | 294.50M | |||
| TOTAL LIABILITIES AND EQUITY | 323.81M | 285.84M | 219.10M | 252.30M | 310.70M | |||
| Statistics | ||||||||
| Debt/Equity | 0.21 | 0.16 | 0.21 | N/A | N/A | |||
| Current Ratio | 10.64 | 15.01 | 11.85 | 16.94 | 19.18 | |||
| Return On Assets (ROA) | -32.20% | -33.20% | -39.99% | -32.12% | -25.66% | |||
| Return On Equity (ROE) | -43.12% | -42.65% | -54.01% | -35.01% | -27.07% | |||
All data in USD